Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy

Technology appraisal guidance
Reference number: TA117
Published: 24 January 2007

History

Documents created during the development process.

Background information

TA117 Hyperparathyroidism - cinacalcet: review decision - July 2013 information
TA117 Hyperparathyroidism - cinacalcet: Appendix A - decision paper presented to the Institute's Guidance Executive
TA117 Hyperparathyroidism - cinacalcet: Appendix A - decision paper presented to the Institute's Guidance Executive (PDF 101 KB)

Published:

01 July 2013
TA117 Hyperparathyroidism - cinacalcet: review proposal - April 2013 information
TA117 Hyperparathyroidism - cinacalcet: Appendix A - provisional matrix of stakeholders
TA117 Hyperparathyroidism - cinacalcet: Appendix A - provisional matrix of stakeholders (PDF 37 KB)

Published:

29 April 2013
TA117 Hyperparathyroidism - cinacalcet: Appendix B - proposal paper presented to the Institute's Guidance Executive
TA117 Hyperparathyroidism - cinacalcet: Appendix B - proposal paper presented to the Institute's Guidance Executive (PDF 342 KB)

Published:

29 April 2013
Review decision - May 2010 information
Appendix A: decision paper considered by the Institute's Guidance Executive
Appendix A: decision paper considered by the Institute's Guidance Executive (PDF 52 KB)

Published:

17 May 2010
TA117 Hyperparathyroidism - cinacalcet: review proposal - February 2010 information
A full list of the organisations contacted for this review
A full list of the organisations contacted for this review (PDF 31 KB)

Published:

12 February 2010
Proposal paper considered by the Institute's Guidance Executive
Proposal paper considered by the Institute's Guidance Executive (PDF 59 KB)

Published:

12 February 2010

Hyperparathroidsom - cinaclacet: Final Appraisal Determination

Hyperparathroidsom - cinaclacet: Final Appraisal Determination information
Final Appraisal Determination: Hyperparathyoidism
Final Appraisal Determination: Hyperparathyoidism (PDF 74 KB)

Published:

03 November 2006
Response to consultee and commentator comments on the ACD
Response to consultee and commentator comments on the ACD (PDF 59 KB)

Published:

03 November 2006
Consultee and commentator comments on the ACD
Welsh Assembly Government
Welsh Assembly Government (PDF 31 KB)

Published:

03 November 2006
North Eastern Derbyshire PCT letter
North Eastern Derbyshire PCT letter (PDF 26 KB)

Published:

03 November 2006
North Eastern Derbyshire PCT
North Eastern Derbyshire PCT (PDF 29 KB)

Published:

03 November 2006
Department of Health
Department of Health (PDF 30 KB)

Published:

03 November 2006
Royal College of Physicians
Royal College of Physicians (PDF 39 KB)

Published:

03 November 2006
Royal College of Pathologists
Royal College of Pathologists (PDF 46 KB)

Published:

03 November 2006
Renal Association
Renal Association (PDF 28 KB)

Published:

03 November 2006
National Kidney Research Fund
National Kidney Research Fund (PDF 67 KB)

Published:

03 November 2006
British Renal Society
British Renal Society (PDF 29 KB)

Published:

03 November 2006
National Kidney Federation
National Kidney Federation (PDF 77 KB)

Published:

03 November 2006
Kidney Alliance
Kidney Alliance (PDF 47 KB)

Published:

03 November 2006
Amgen
Amgen (PDF 45 KB)

Published:

03 November 2006
NHS Quality Improvement Scotland
NHS Quality Improvement Scotland (PDF 27 KB)

Published:

03 November 2006

Hyperparathyroidism - cinacalcet HCl, second appraisal consultation

Hyperparathyroidism - cinacalcet HCl, second appraisal consultation
Hyperparathyroidism - cinacalcet HCI, Second Appraisal Consultation Document information
Response to consultee and comentator comments on the first ACD
Response to consultee and comentator comments on the first ACD (PDF 159 KB)

Published:

17 August 2006
Response to public and web comments on the first ACD
Response to public and web comments on the first ACD (PDF 39 KB)

Published:

17 August 2006
Expert comments on the first ACD
Payne
Payne (PDF 19 KB)

Published:

17 August 2006
Gittoes
Gittoes (PDF 21 KB)

Published:

17 August 2006
Consultee and commentator comments on the first ACD
Welsh Assembly Government
Welsh Assembly Government (PDF 84 KB)

Published:

17 August 2006
North East Derbyshire Primary Care Trust
North East Derbyshire Primary Care Trust (PDF 22 KB)

Published:

17 August 2006
Royal College of Pathologists
Royal College of Pathologists (PDF 32 KB)

Published:

17 August 2006
Royal College of Nursing
Royal College of Nursing (PDF 23 KB)

Published:

17 August 2006
Renal Association
Renal Association (PDF 21 KB)

Published:

17 August 2006
British Renal Society
British Renal Society (PDF 21 KB)

Published:

17 August 2006
Kidney Alliance
Kidney Alliance (PDF 17 KB)

Published:

17 August 2006
Amgen
Amgen (PDF 211 KB)

Published:

17 August 2006
NHS Quality Improvement Scotland
NHS Quality Improvement Scotland (PDF 29 KB)

Published:

17 August 2006

Hyperparathyroidism - cinacalcet HCl, first appraisal consultation

Hyperparathyroidism - cinacalcet HCl, first appraisal consultation
Hyperparathyroidism - cinacalcet HCI, First Appraisal Consultation Document information
Hyperparathyroidism - cinacalcet HCI, Overview
Hyperparathyroidism - cinacalcet HCI, Overview (PDF 154 KB)

Published:

22 June 2006
Hyperparathyroidism - cinacalcet HCI, Assessment report
Hyperparathyroidism - cinacalcet HCI, Assessment report (PDF 1.66 MB)

Published:

22 June 2006
Expert written personal statements
Steve Rowe
Steve Rowe (PDF 41 KB)

Published:

22 June 2006
Chris Payne
Chris Payne (PDF 22 KB)

Published:

22 June 2006
Alastair Hutchison
Alastair Hutchison (PDF 28 KB)

Published:

22 June 2006
Neil Gittoes
Neil Gittoes (PDF 23 KB)

Published:

22 June 2006
Amgen Executive Summary
Amgen Executive Summary (PDF 242 KB)

Published:

22 June 2006
Non manufacturer submissions
UK Renal Pharmacy Group
UK Renal Pharmacy Group (PDF 148 KB)

Published:

22 June 2006
Society for Endocrinology
Society for Endocrinology (PDF 309 KB)

Published:

22 June 2006
Royal College of Physicians
Royal College of Physicians (PDF 38 KB)

Published:

22 June 2006
Royal College of Physicians - cover letter
Royal College of Physicians - cover letter (PDF 29 KB)

Published:

22 June 2006
Royal College of Nursing (2)
Royal College of Nursing (2) (PDF 54 KB)

Published:

22 June 2006
Royal College of Nursing (1)
Royal College of Nursing (1) (PDF 20 KB)

Published:

22 June 2006
Renal Association
Renal Association (PDF 42 KB)

Published:

22 June 2006
National Kidney Federation
National Kidney Federation (PDF 123 KB)

Published:

22 June 2006
Kidney Research UK
Kidney Research UK (PDF 195 KB)

Published:

22 June 2006
British Renal Society
British Renal Society (PDF 86 KB)

Published:

22 June 2006
Consultee and commentator comments on the assessment report
Welsh Assembly Government
Welsh Assembly Government (PDF 34 KB)

Published:

22 June 2006
Royal College of Physicans
Royal College of Physicans (PDF 38 KB)

Published:

22 June 2006
Royal College of Pathologists
Royal College of Pathologists (PDF 57 KB)

Published:

22 June 2006
Royal College of Nursing (1)
Royal College of Nursing (1) (PDF 20 KB)

Published:

22 June 2006
NHS Quality Improvement Scotland
NHS Quality Improvement Scotland (PDF 20 KB)

Published:

22 June 2006
Amgen Ltd
Amgen Ltd (PDF 210 KB)

Published:

22 June 2006
Amgen Ltd - covering letter
Amgen Ltd - covering letter (PDF 31 KB)

Published:

22 June 2006

Hyperparathyroidism - cinacalcet HCl, Final protocol

Hyperparathyroidism - cinacalcet HCl, Final protocol
Hyperparathyroidism - cinacalcet HCl, Final protocol (PDF 134 KB)

Published:

20 September 2005

Hyperparathyroidism - cinacalcet HCl, Final scope

Hyperparathyroidism - cinacalcet HCl, Final scope
Hyperparathyroidism - cinacalcet HCl, Final scope (PDF 33 KB)

Published:

15 August 2005

Hyperparathyroidism - cinacalcet HCl, Summary of Consultee and commentator comments on the draft scope

Hyperparathyroidism - cinacalcet HCl, Summary of Consultee and commentator comments on the draft scope
Hyperparathyroidism - cinacalcet HCl, Summary of Consultee and commentator comments on the draft scope (PDF 41 KB)

Published:

15 August 2005

Hyperparathyroidism - cinacalcet HCl, Summary of Consultee and commentator comments on the draft matrix

Hyperparathyroidism - cinacalcet HCl, Summary of Consultee and commentator comments on the draft matrix
Hyperparathyroidism - cinacalcet HCl, Summary of Consultee and commentator comments on the draft matrix (PDF 43 KB)

Published:

20 September 2005

(Archive): Hyperparathyroidism - cinacalcet HCl, draft scope

(Archive): Hyperparathyroidism - cinacalcet HCl, draft scope
(Archive): Hyperparathyroidism - cinacalcet HCl, draft scope (PDF 27 KB)

Published:

01 June 2005

(Archive): Hyperparathyroidism - cinacalcet HCl, provisional matrix

(Archive): Hyperparathyroidism - cinacalcet HCl, provisional matrix
(Archive): Hyperparathyroidism - cinacalcet HCl, provisional matrix (PDF 23 KB)

Published:

01 June 2005